stockrow
Friday 6 November 2026
Export OMDA’s income statement to Excel — free account
Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
- Revenue
- +34.2%
- EPS
- +283.3%
- Free cash flow
- +65.8%
Quarter to September 2026, against a year earlier
15.10
3.85
−20.32%
Follow OMDA
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
86.71 | 313.57 | 0.00 | 0.00 |
+7 more quarters Free account |
P/S ratio |
3.84 | 4.23 | 2.61 | 2.22 | |
P/FCF ratio |
56.90 | 76.47 | 45.17 | 46.55 | |
P/Operating CF |
84.53 | 326.95 | (62.59) | 27.04 | |
P/B ratio |
4.69 | 5.18 | 3.16 | 2.52 | |
Price to Tangible BV |
4.95 | 5.51 | 3.38 | 2.70 | |
EV/Sales |
3.20 | 3.61 | 1.97 | 1.48 | |
EV/EBITDA |
116.34 | 121.98 | 533.27 | 0.00 | |
EV/Operating CF |
37.17 | 47.22 | 24.80 | 21.15 | |
EV/FCF |
47.42 | 65.28 | 34.09 | 31.09 | |
Quick Ratio |
3.87 | 3.69 | 3.67 | 3.39 | |
Current Ratio |
4.18 | 3.91 | 3.92 | 3.60 | |
Net Debt/EBITDA |
0.00 | (36.36) | 91.48 | (39.65) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.05 | 0.98 | 1.87 | 1.70 | |
Operating CF/Net income |
2.31 | 0.76 | 3.98 | 4.14 | |
Capex/Depreciation |
0.00 | (0.65) | (0.63) | (0.58) | |
Interest Coverage |
18.40 | 253.50 | (265.61) | 252.38 | |
Research and Development Expense of Revenue |
16.73% | 16.65% | 16.27% | 15.23% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 51.93% | 52.25% | 51.19% | |
Intangible Assets out of Total Assets |
0.04 | 0.05 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
6.41% | 6.41% | 5.39% | 4.94% | |
Graham Net Nets |
0.19 | 0.17 | 0.27 | 0.34 | |
Graham Number |
4.90 | 2.58 | 0.00 | 0.00 | |
Earnings Yield |
1.15% | 0.32% | (2.07%) | (8.60%) | |
Free Cash Flow Yield |
1.76% | 1.31% | 2.21% | 2.15% | |
Revenue per Share |
1.48 | 1.47 | 1.32 | 2.07 | |
Operating CF per Share |
0.25 | 0.07 | (0.20) | 0.58 | |
Capex per Share |
(0.03) | (0.03) | (0.03) | (0.04) | |
Free Cash Flow per Share |
0.22 | 0.04 | (0.23) | 0.55 | |
Cash per Share |
3.95 | 3.71 | 3.59 | 6.06 | |
Shareholders Equity per Share |
4.44 | 4.23 | 3.97 | 6.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.44 | 4.23 | 3.97 | 6.27 | |
Free Cash Flow |
13.51 | 2.34 | (13.39) | 20.03 | |
Working Capital |
239.68 | 219.43 | 200.75 | 197.21 | |
Capital Expenditures |
(1.63) | (1.66) | (1.56) | (1.35) | |
Net Current Asset Value |
239.68 | 219.43 | 200.75 | 197.21 | |
EV/EBIT |
155.28 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Price to Operating Income |
186.31 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
44.82 | 44.93 | 31.70 | — | |
Average Payables |
6.86 | 9.60 | 6.13 | — | |
Average Inventory |
4.01 | 3.79 | 3.56 | — | |
Average Assets |
318.00 | 315.60 | 151.40 | 152.70 | |
Average Common Equity |
245.22 | 233.48 | (75.14) | — |
Columns are period end dates · fundamentals updated 6 Nov 2026